Figure 2

Clomipramine treatment results in a dose-dependent inhibition of flank marking behavioral following two weeks of clomipramine treatment. Flank marking was triggered by the microinjection of 1.0 μM AVP in the anterior hypothalamus.
Clomipramine treatment results in a dose-dependent inhibition of flank marking behavioral following two weeks of clomipramine treatment. Flank marking was triggered by the microinjection of 1.0 μM AVP in the anterior hypothalamus.